CSCCS

AcronymDefinition
CSCCSCSC Consulting Services (various locations)
CSCCSCentral States Consortium of Colleges & Schools
CSCCSCombat Systems Casualty Control System
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Migden for the first time at the Mohs surgery meeting in recognition of the subspecialty's essential role in this serious malignancy --along with the thus-far confirmatory results of EMPOWER-CSCC-1, an ongoing, larger, pivotal phase 2 trial, cemiplimab is currently under review by both regulatory agencies for approval as a potential therapy for advanced CSCC.
Care for larger, advanced CSCC falls within our scope of practice and we should play an essential role, inclusive of multidisciplinary care, in the management and follow-up of these patients," asserted Dr.
Our preceding measurements of nematocyst-mediated adhesive force and nematocyst discharge were done under conditions that elicited maximum discharge from both Type B and Type C CSCCs. Therefore, the results in Figure 3A-C represent the combined effects from both types of CSCC.
Upon closer inspection, satiation had little or no effect on the number of nematocysts discharged from Type C CSCCs in A.
The vast majority of patients with cSCC are men, usually in the 6th decade of life.
The 5-year survival rate for patients with cSCC exceeds 75%.
To test our hypotheses that a nematocyst release response exists and is under the control of prey-derived chemicals, we ask the research question: Do known chemosensitizers of nematocyst discharge lower, in a dose-dependent manner, the values of [i.sub.m] for nematocysts discharged from either Type B or Type C CSCCs? To answer this question we proposed to determine the intrinsic adherence (ira values) for nematocysts discharged from Type B and from Type C CSCCs as a function of chemosensitizer concentration.
D-600 inhibits discharge from Type B CSCCs. D-600 potently and dose-dependently inhibits nematocyst discharge from NANA-sensitized Type Bs ([ILLUSTRATION FOR FIGURE 1 OMITTED]; open circles).
From the slope of this extrapolated line, we calculate that the mean intrinsic adherence of all discharging mastigophores (i.e., from both Type B and Type C CSCCs) is 0.18 mgf (1.76 [[micro]neuton]); a value more than ten times that of the average value of [i.sub.s] (Table II).
Considering the increasing incidence in cSCC and the risk of metastasis and recurrence, even in patients with negative histological margins and lymph nodes, it is necessary to identify circulating molecules that can help predict the prognosis/evolution of this pathology [18-24].